These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8151484)

  • 1. Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis.
    Lang BA; Finlayson LA
    J Pediatr; 1994 Apr; 124(4):639-42. PubMed ID: 8151484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naproxen-induced pseudoporphyria: appearance of new skin lesions after discontinuation of treatment.
    Girschick HJ; Hamm H; Ganser G; Huppertz HI
    Scand J Rheumatol; 1995; 24(2):108-11. PubMed ID: 7747141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
    De Silva B; Banney L; Uttley W; Luqmani R; Schofield O
    Pediatr Dermatol; 2000; 17(6):480-3. PubMed ID: 11123786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen-induced pseudoporphyria: a distinctive photodermatitis.
    Levy ML; Barron KS; Eichenfield A; Honig PJ
    J Pediatr; 1990 Oct; 117(4):660-4. PubMed ID: 2213398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoporphyria induced by propionic acid derivatives.
    Al-Khenaizan S; Schechter JF; Sasseville D
    J Cutan Med Surg; 1999 Jan; 3(3):162-6. PubMed ID: 10082597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen induced pseudoporphyria in juvenile chronic arthritis.
    Allen R; Rogers M; Humphrey I
    J Rheumatol; 1991 Jun; 18(6):893-6. PubMed ID: 1895270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naproxen-induced pseudoporphyria.
    Sterling JC; Pye RJ
    Br J Rheumatol; 1987 Jun; 26(3):210-1. PubMed ID: 3580714
    [No Abstract]   [Full Text] [Related]  

  • 8. Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.
    Schäd SG; Kraus A; Haubitz I; Trcka J; Hamm H; Girschick HJ
    Arthritis Res Ther; 2007; 9(1):R10. PubMed ID: 17266758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoporphyria due to naproxen. A cluster of 3 cases.
    Creemers MC; Chang A; Franssen MJ; Fiselier TJ; van Riel PL
    Scand J Rheumatol; 1995; 24(3):185-7. PubMed ID: 7777834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bullae, erosions and scars in the face of 2 girls with idiopathic arthritis. Naproxen-induced pseudoporphyria].
    Schäd SG; Hamm H; Girschick HJ
    Hautarzt; 2002 Jan; 53(1):51-3. PubMed ID: 11963225
    [No Abstract]   [Full Text] [Related]  

  • 11. Case 1: Naproxen-induced pseudoporphyria.
    O'Donoghue NB; Higgins EM
    Clin Exp Dermatol; 2002 Jun; 27(4):339-40. PubMed ID: 12139696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Naproxen-induced pseudoporphyria].
    Maerker JM; Harm A; Foeldvari I; Höger PH
    Hautarzt; 2001 Nov; 52(11):1026-9. PubMed ID: 11757457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous photosensitivity to naproxen: "pseudoporphyria".
    Suarez SM; Cohen PR; DeLeo VA
    Arthritis Rheum; 1990 Jun; 33(6):903-8. PubMed ID: 2194465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of facial scars in children taking nonsteroidal antiinflammatory drugs.
    Wallace CA; Farrow D; Sherry DD
    J Pediatr; 1994 Nov; 125(5 Pt 1):819-22. PubMed ID: 7965441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Naproxen-induced bullous photodermatitis (pseudoporphyria)].
    Lützow-Holm C
    Tidsskr Nor Laegeforen; 1991 Sep; 111(22):2739-40. PubMed ID: 1835183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoporphyria secondary to non-steroidal anti-inflammatory drugs.
    Bryant P; Lachman P
    Arch Dis Child; 2003 Nov; 88(11):961. PubMed ID: 14612354
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
    Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH
    J Rheumatol; 2006 May; 33(5):985-95. PubMed ID: 16583464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis.
    Mehta S; Lang B
    Arthritis Rheum; 1999 Oct; 42(10):2252-4. PubMed ID: 10524703
    [No Abstract]   [Full Text] [Related]  

  • 19. Piroxicam in juvenile rheumatoid arthritis.
    García-Morteo O; Maldonado-Cocco JA; Cuttica R; Garay SM
    Eur J Rheumatol Inflamm; 1987; 8(1):49-53. PubMed ID: 2957205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs.
    Meggitt SJ; Farr PM
    Br J Dermatol; 1999 Sep; 141(3):591-2. PubMed ID: 10583088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.